NexelisWith unrivaled expertise in immunology on both sides of the client/CRO relationship, we are a leading provider of assay development and specialty laboratory testing. Our versatile team of scientists, working with our advanced technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 100 new molecular entities, including blockbuster vaccines and soluble large molecules.
In addition, Nexelis has developed various preclinical in vitro and in vivo models to support the development of multiple candidates in the fields of infectious disease, immune disorders, and immuno-oncology. Whether for vaccines, immunotherapeutics or other biologically active molecules, we have the flexibility to adapt the readouts to fit the needs
